Spyre Therapeutics
SYRE
#4930
Rank
ยฃ1.11 B
Marketcap
ยฃ18.98
Share price
3.16%
Change (1 day)
32.66%
Change (1 year)

Operating Margin for Spyre Therapeutics (SYRE)

Operating Margin as of December 2024 (TTM): -38,241.10%

According to Spyre Therapeutics's latest financial reports and stock price the company's current Operating Margin is -38,241.10%. At the end of 2023 the company had an Operating Margin of -38,241.08%.

Operating Margin history for Spyre Therapeutics from 2016 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2023-38,241.08%960.9%
2022-3,604.59%928.73%
2021-350.39%
2018-1,140.64%117.98%
2017-523.27%11.61%
2016-468.84%152.58%
2015-185.62%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.